Translational Development Acquisition Stock Performance

TDAC Stock  USD 10.51  0.03  0.28%   
Translational Development has a performance score of 7 on a scale of 0 to 100. The entity has a beta of 0.023, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Translational Development's returns are expected to increase less than the market. However, during the bear market, the loss of holding Translational Development is expected to be smaller as well. Translational Development right now has a risk of 0.13%. Please validate Translational Development coefficient of variation, sortino ratio, potential upside, as well as the relationship between the jensen alpha and maximum drawdown , to decide if Translational Development will be following its existing price patterns.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Translational Development Acquisition are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Translational Development is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more

Actual Historical Performance (%)

One Day Return
(0.27)
Five Day Return
(0.1)
Year To Date Return
0.19
Ten Year Return
5
All Time Return
5
1
Real Time Data Flags Unusual Activity in Innovative Ideals and Services India Limited - Growth Stock Opportunities Superior Capital Investment - earlytimes.in
12/16/2025
2
Vijaya Diagnostic Centre Limited Hits 52 Week High - Covered Call Writing High Return Investment Growth - Bollywood Helpline
12/23/2025
3
Brookfield India Real Estate Trust Approaches Support With Recovery in Sight - AI-Driven Market Analysis Todays Picks, Tomorrows Winners - bollywoodhelpline.com
01/06/2026
4
What insider trading reveals about Translational Development Acquisition Corp. stock - Weekly Investment Summary Short-Term High Return Strategies - ulpravda.ru
01/09/2026
5
Experimental cancer drug targets hidden resistance driving metastasis - Stock Titan
01/30/2026
6
Will Translational Development Acquisition Corp. stock remain a Wall Street favorite - 2025 Macro Impact Weekly Chart Analysis and Trade Guides - mfd.ru
02/12/2026
Begin Period Cash Flow2021.00
Total Cashflows From Investing Activities-174.2 M

Translational Development Relative Risk vs. Return Landscape

If you would invest  1,043  in Translational Development Acquisition on November 17, 2025 and sell it today you would earn a total of  8.00  from holding Translational Development Acquisition or generate 0.77% return on investment over 90 days. Translational Development Acquisition is currently generating 0.0124% in daily expected returns and assumes 0.1296% risk (volatility on return distribution) over the 90 days horizon. In different words, 1% of stocks are less volatile than Translational, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Translational Development is expected to generate 8.12 times less return on investment than the market. But when comparing it to its historical volatility, the company is 5.9 times less risky than the market. It trades about 0.1 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 of returns per unit of risk over similar time horizon.

Translational Development Target Price Odds to finish over Current Price

The tendency of Translational Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 10.51 90 days 10.51 
about 16.34
Based on a normal probability distribution, the odds of Translational Development to move above the current price in 90 days from now is about 16.34 (This Translational Development Acquisition probability density function shows the probability of Translational Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Translational Development has a beta of 0.023. This usually implies as returns on the market go up, Translational Development average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Translational Development Acquisition will be expected to be much smaller as well. Additionally Translational Development Acquisition has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Translational Development Price Density   
       Price  

Predictive Modules for Translational Development

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Translational Development. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
10.3810.5110.64
Details
Intrinsic
Valuation
LowRealHigh
8.698.8211.56
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Translational Development. Your research has to be compared to or analyzed against Translational Development's peers to derive any actionable benefits. When done correctly, Translational Development's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Translational Development.

Translational Development Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Translational Development is not an exception. The market had few large corrections towards the Translational Development's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Translational Development Acquisition, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Translational Development within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.0026
β
Beta against Dow Jones0.02
σ
Overall volatility
0.04
Ir
Information ratio -0.48

Translational Development Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Translational Development for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Translational Development can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Translational Development has high likelihood to experience some financial distress in the next 2 years
Translational Development Acquisition currently holds 6.11 T in liabilities with Debt to Equity (D/E) ratio of 1.01, which is about average as compared to similar companies. Translational Development has a current ratio of 0.19, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Translational Development's use of debt, we should always consider it together with its cash and equity.
Net Loss for the year was (71.01 K) with profit before overhead, payroll, taxes, and interest of 0.
Translational Development Acquisition currently holds about 972.79 K in cash with (851.45 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.13.
Translational Development has a frail financial position based on the latest SEC disclosures
Over 93.0% of Translational Development shares are owned by institutional investors
Latest headline from news.google.com: Will Translational Development Acquisition Corp. stock remain a Wall Street favorite - 2025 Macro Impact Weekly Chart Analysis and Trade Guides - mfd.ru

Translational Development Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Translational Stock often depends not only on the future outlook of the current and potential Translational Development's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Translational Development's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares OutstandingM
Cash And Short Term Investments438.2 K

Translational Development Fundamentals Growth

Translational Stock prices reflect investors' perceptions of the future prospects and financial health of Translational Development, and Translational Development fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Translational Stock performance.

About Translational Development Performance

By analyzing Translational Development's fundamental ratios, stakeholders can gain valuable insights into Translational Development's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Translational Development has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Translational Development has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year

Things to note about Translational Development performance evaluation

Checking the ongoing alerts about Translational Development for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Translational Development help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Translational Development has high likelihood to experience some financial distress in the next 2 years
Translational Development Acquisition currently holds 6.11 T in liabilities with Debt to Equity (D/E) ratio of 1.01, which is about average as compared to similar companies. Translational Development has a current ratio of 0.19, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Translational Development's use of debt, we should always consider it together with its cash and equity.
Net Loss for the year was (71.01 K) with profit before overhead, payroll, taxes, and interest of 0.
Translational Development Acquisition currently holds about 972.79 K in cash with (851.45 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.13.
Translational Development has a frail financial position based on the latest SEC disclosures
Over 93.0% of Translational Development shares are owned by institutional investors
Latest headline from news.google.com: Will Translational Development Acquisition Corp. stock remain a Wall Street favorite - 2025 Macro Impact Weekly Chart Analysis and Trade Guides - mfd.ru
Evaluating Translational Development's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Translational Development's stock performance include:
  • Analyzing Translational Development's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Translational Development's stock is overvalued or undervalued compared to its peers.
  • Examining Translational Development's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Translational Development's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Translational Development's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Translational Development's stock. These opinions can provide insight into Translational Development's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Translational Development's stock performance is not an exact science, and many factors can impact Translational Development's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Translational Stock analysis

When running Translational Development's price analysis, check to measure Translational Development's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Translational Development is operating at the current time. Most of Translational Development's value examination focuses on studying past and present price action to predict the probability of Translational Development's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Translational Development's price. Additionally, you may evaluate how the addition of Translational Development to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments